The activation of SRC family kinases and subsequent signalling pathways that promote cancer cell proliferation, apoptosis resistance, migration and invasion in different cancer cell lines are triggered by the binding of glutamate to receptors [122]. The gene discussed is SRC; the disease is cancer.